| 2020-12-14 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 111,125 0.0429% | $23.88 | $2.65M | -55.86% | |
| 2020-10-09 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 193,700 0.0743% | $15.03 | $2.91M | -28.7% | |
| 2020-02-12 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 126,712 0.0486% | $11.01 | $1.39M | +31% | |
| 2019-01-16 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 73,338 0.034% | $12.05 | $883,723 | -6.7% | |
| 2019-01-15 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 33,200 0.0156% | $12.00 | $398,400 | -5.17% | |
| 2018-06-01 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 50,000 0.0268% | $16.72 | $836,000 | -23.65% | |
| 2018-05-16 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 50,000 0.0248% | $15.00 | $750,000 | -19.43% | |
| 2018-04-17 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 100,000 0.0539% | $15.00 | $1.5M | -10.75% | |
| 2017-10-12 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 100,388 0.0624% | $14.25 | $1.43M | +1.4% | |
| 2017-05-19 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 59,828 0.0431% | $8.00 | $478,624 | +78.89% | |
| 2017-05-15 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 59,828 0.0435% | $8.00 | $478,624 | +80.36% | |
| 2017-02-07 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 50,000 0.0349% | $6.00 | $300,000 | +114.2% | |
| 2017-01-13 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 50,000 0.0353% | $6.00 | $300,000 | +108.57% | |
| 2016-11-01 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 50,000 0.0228% | $7.00 | $350,000 | +17.11% | |
| 2016-10-03 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 50,000 0.0219% | $7.25 | $362,500 | +3% | |
| 2016-09-06 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 50,000 0.0354% | $7.00 | $350,000 | +6.27% | |
| 2016-08-04 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 50,000 0.0365% | $7.00 | $350,000 | +5.65% | |
| 2015-09-15 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Science Officer | 50,000 0.041% | $17.75 | $887,335 | -61.05% |